of unsuccessful experiments, and billions of dollars in investment. The profits from successful medicines finance the research that produces tomorrow’s cures.
If government policies significantly reduce those returns, companies are unlikely to stop producing today’s medicines. More likely, they will reduce research and development spending, slowing continue reading …
